Pacira Biosciences, Inc.
(NASDAQ : PCRX)

( )
PCRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
23.83%20.941.7%$162.94m
VRXValeant Pharmaceuticals International, Inc.
1.85%27.0114.1%$158.93m
BHCBausch Health Cos., Inc.
1.85%27.010.0%$119.66m
GWPHGW Pharmaceuticals Plc
-3.38%109.406.2%$81.05m
MDCOThe Medicines Co.
-3.58%53.3920.2%$78.63m
JAZZJazz Pharmaceuticals Plc
1.11%132.332.3%$69.12m
SAGESAGE Therapeutics, Inc.
-1.93%141.558.6%$52.41m
PRGOPerrigo Co. Plc
-1.67%48.286.8%$46.00m
ENDPEndo International Plc
0.61%4.148.8%$44.46m
HZNPHorizon Therapeutics Plc
0.73%30.236.6%$40.27m
UTHRUnited Therapeutics Corp.
-1.53%89.5714.3%$39.81m
ICPTIntercept Pharmaceuticals, Inc.
1.29%83.0216.9%$39.56m
ICLRICON plc
0.73%147.244.1%$37.50m
CTLTCatalent, Inc.
-0.74%49.482.4%$32.17m
AERIAerie Pharmaceuticals, Inc.
-0.89%18.886.8%$26.95m

Company Profile

Pacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.